123 related articles for article (PubMed ID: 8548037)
1. p53 mutation in carcinomas arising in ovarian cystic teratomas.
Fujii T; Oguni S; Kikuchi M; Kanai N; Saito K
Pathol Int; 1995 Sep; 45(9):649-54. PubMed ID: 8548037
[TBL] [Abstract][Full Text] [Related]
2. Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus.
Snijders PJ; Steenbergen RD; Top B; Scott SD; Meijer CJ; Walboomers JM
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2769-75. PubMed ID: 7931165
[TBL] [Abstract][Full Text] [Related]
3. Detection of human papillomavirus in squamous cell carcinoma arising from dermoid cysts.
Chiang AJ; Chen DR; Cheng JT; Chang TH
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):559-66. PubMed ID: 26522111
[TBL] [Abstract][Full Text] [Related]
4. Is it possible to diagnose malignancy from fluid in cystic ovarian tumors?
Yamada R; Maeda N; Oguri H; Adachi Y; Takeuchi T; Furihata M; Fukaya T
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):96-100. PubMed ID: 24017961
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical and molecular studies on malignant transformation in mature cystic teratoma of the ovary.
Yoshioka T; Tanaka T
J Obstet Gynaecol Res; 1998 Apr; 24(2):83-90. PubMed ID: 9631595
[TBL] [Abstract][Full Text] [Related]
6. p53 mutation is infrequent in clear cell carcinoma of the ovary.
Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
[TBL] [Abstract][Full Text] [Related]
7. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
8. HPV and p53 expression in epithelial ovarian carcinoma.
Kuscu E; Ozdemir BH; Erkanli S; Haberal A
Eur J Gynaecol Oncol; 2005; 26(6):642-5. PubMed ID: 16398227
[TBL] [Abstract][Full Text] [Related]
9. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation rate and p53, and p16 expression in teratomatous skin of ovarian mature cystic teratoma.
Zhu HL; Zou ZN; Lin PX; Li WX; Huang YE; Shi XX; Shen H
Asian Pac J Cancer Prev; 2015; 16(3):1165-8. PubMed ID: 25735349
[TBL] [Abstract][Full Text] [Related]
11. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.
Chang F; Syrjänen S; Tervahauta A; Kurvinen K; Wang L; Syrjänen K
Br J Cancer; 1994 Aug; 70(2):346-51. PubMed ID: 8054284
[TBL] [Abstract][Full Text] [Related]
12. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas.
Kim YT; Thomas NF; Kessis TD; Wilkinson EJ; Hedrick L; Cho KR
Hum Pathol; 1996 Apr; 27(4):389-95. PubMed ID: 8617483
[TBL] [Abstract][Full Text] [Related]
13. p53 mutations in ovarian tumors, detected by temperature-gradient gel electrophoresis, direct sequencing and immunohistochemistry.
Kappes S; Milde-Langosch K; Kressin P; Passlack B; Dockhorn-Dworniczak B; Röhlke P; Löning T
Int J Cancer; 1995 Feb; 64(1):52-9. PubMed ID: 7665249
[TBL] [Abstract][Full Text] [Related]
14. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ
J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074
[TBL] [Abstract][Full Text] [Related]
15. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
[TBL] [Abstract][Full Text] [Related]
16. p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.
Busby-Earle RM; Steel CM; Williams AR; Cohen B; Bird CC
Br J Cancer; 1994 Apr; 69(4):732-7. PubMed ID: 8142262
[TBL] [Abstract][Full Text] [Related]
17. HPV DNA and p53 alterations in oropharyngeal carcinomas.
Barten M; Ostwald C; Milde-Langosch K; Müller P; Wukasch Y; Löning T
Virchows Arch; 1995; 427(2):153-7. PubMed ID: 7582245
[TBL] [Abstract][Full Text] [Related]
18. TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas.
Malisic E; Jankovic R; Jakovljevic K; Radulovic S
J BUON; 2011; 16(4):701-7. PubMed ID: 22331725
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL
J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348
[TBL] [Abstract][Full Text] [Related]
20. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.
Zheng J; Benedict WF; Xu HJ; Hu SX; Kim TM; Velicescu M; Wan M; Cofer KF; Dubeau L
J Natl Cancer Inst; 1995 Aug; 87(15):1146-53. PubMed ID: 7674319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
